The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?

Article English OPEN
Castagnola, Sara; Bardoni, Barbara; Maurin, Thomas; (2017)
  • Publisher: Frontiers Media S.A.
  • Journal: Frontiers in Synaptic Neuroscience,volume 9 (issn: 1663-3563, eissn: 1663-3563)
  • Related identifiers: doi: 10.3389/fnsyn.2017.00015/full, doi: 10.3389/fnsyn.2017.00015, pmc: PMC5681520
  • Subject: oxytocin | Neurosciences. Biological psychiatry. Neuropsychiatry | RC321-571 | Neuroscience | MMP-9 | serotonin | ASD | Fragile X Syndrome | FMR1 | Mini Review | endocannabinoid system | IGF-1
    mesheuropmc: congenital, hereditary, and neonatal diseases and abnormalities

Fragile X Syndrome (FXS) is the most common form of intellectual disability and a primary cause of autism. It originates from the lack of the Fragile X Mental Retardation Protein (FMRP), which is an RNA-binding protein encoded by the Fragile X Mental Retardation Gene 1 ... View more
Share - Bookmark